SV News
22 August 2022Portfolio NewsImbria Pharmaceuticals to Present Phase 2a Data from the Ninerafaxstat Program at the European Society of Cardiology Congress 2022
26 May 2022Portfolio NewsAlchemab appoints Young T. Kwon as Chief Executive Officer
25 May 2022Portfolio NewsPrilenia Announces Publication of Data Elucidating a Mechanism for Neuroprotective Potential of Pridopidine- 12 April 2022Portfolio NewsSV Health Investors Joins Prilenia Series B as the Company Prepares for ALS and HD Data Readouts in the Next 12 Months
10 April 2022SV NewsLife Sciences Summit: venture capital plugs gap in funding- 5 April 2022Portfolio NewsCatamaran Bio Appoints Frank Lee as Chair of its Board of Directors
31 March 2022SV NewsKate Bingham interviewed by Beth Rigby, Sky News, on the lessons learnt from the UK Vaccine Taskforce- 30 March 2022SV NewsKate Bingham shared the key lessons learnt from the success of the UK Vaccine Taskforce at The Royal Society’s recent Science of COVID-19 event.
2 March 2022Portfolio NewsRondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors- 22 February 2022Portfolio NewsEyeBio Raises $65M in Series A Funding to Develop New Generation of Eye Disease Therapies
29 November 2021Portfolio NewsQuell Therapeutics Raises $156 million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform
10 November 2021Portfolio NewsSitryx appoints Tanya E. Borsuk, Ph.D., as Chief Business Officer
